Cargando…

Analysis of subjects with menstrually related migraine vs. Non-menstrually related migraine treated with MAP0004

Detalles Bibliográficos
Autores principales:	Aurora, S, Lu, B, Connors, E, Li, X, Kellerman, D, Kori, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620240/ http://dx.doi.org/10.1186/1129-2377-14-S1-P143

Ejemplares similares

Efficacy of MAP0004 in treating severe migraine
por: Kori, S, et al.
Publicado: (2013)

MAP0004 provided consistent migraine pain relief even after repeated administration
por: Kori, S, et al.
Publicado: (2013)

Menstrual migraines
por: Granella, Franco
Publicado: (2015)

Menstrual migraine, migraine and contraceptions, migraine and pregnancy and migraine triggers
por: MacGregor, Anne
Publicado: (2013)

Brain structural and functional differences between pure menstrual migraine and menstrually-related migraine
por: Xu, Tao, et al.
Publicado: (2020)

Menstrual migraine
por: Moschiano, Franca, et al.
Publicado: (2001)

Menstrual migraine and SPECT
por: Karakurum, Bašak, et al.
Publicado: (2002)

EHMTI-0230. Characteristics of menstrual and nonmenstrual migraine attacks in women with menstrual migraine
por: Vetvik, KG, et al.
Publicado: (2014)

Pain perception in women with menstrually-related migraine
por: Linstra, Katie M, et al.
Publicado: (2020)

Frovatriptan vs almotriptan for treatment of menstrual migraine: a double-blind, randomized, cross-over, multicenter Italian study
por: Bartolini, M, et al.
Publicado: (2013)

Comparison Between Menstrual Migraine and Menstrual-Unrelated Migraine in Women Attending Gynecology Clinics
por: Abdullah, Mohammad, et al.
Publicado: (2020)

Frovatriptan vs other triptans in the treatment of menstrual migraine: pooled analysis of three double-blind, randomized, cross-over studies
por: Allais, G, et al.
Publicado: (2013)

Role of Estrogens in Menstrual Migraine
por: Nappi, Rossella E., et al.
Publicado: (2022)

Differences in topological properties of functional brain networks between menstrually-related and non-menstrual migraine without aura
por: Zhang, Yutong, et al.
Publicado: (2020)

Evolution of migraine-associated symptoms in menstrually related migraine following symptomatic treatment with almotriptan
por: Allais, Gianni, et al.
Publicado: (2010)

Are Menstrual and Nonmenstrual Migraine Attacks Different?
por: Vetvik, Kjersti Grøtta, et al.
Publicado: (2011)

Genetics of Menstrual Migraine: The Epidemiological Evidence
por: Russell, Michael Bjørn
Publicado: (2010)

Frovatriptan vs. transdermal oestrogens or naproxen sodium for the prophylaxis of menstrual migraine
por: Guidotti, Mario, et al.
Publicado: (2007)

Consistency vs. switching triptan treatment and headache-related disability: Results of the American migraine prevalence & prevention study
por: Buse, DC, et al.
Publicado: (2013)

Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study
por: Grazzi, Licia, et al.
Publicado: (2016)

Frovatriptan plus dexketoprofen in the treatment of menstrually related migraine: an open study
por: Allais, Gianni, et al.
Publicado: (2013)

Sustained pain relief with dihydroergotamine in migraine is potentially due to persistent binding to 5-HT1B and 5-HT1D receptors
por: Kori, S, et al.
Publicado: (2013)

Self-reported menstrual migraine in the general population
por: Vetvik, Kjersti Grøtta, et al.
Publicado: (2010)

A review of frovatriptan for the treatment of menstrual migraine
por: MacGregor, E Anne
Publicado: (2014)

Acupuncture for menstrual migraine: a systematic review
por: Yang, Mingxiao, et al.
Publicado: (2022)

Characteristics of menstrual versus non-menstrual migraine during pregnancy: a longitudinal population-based study
por: Petrovski, Beáta Éva, et al.
Publicado: (2018)

Managing migraine headaches experienced by patients who self–report with menstrually related migraine: a prospective, placebo–controlled study with oral sumatriptan
por: Dowson, A. J., et al.
Publicado: (2005)

Vitamin Supplementation as Possible Prophylactic Treatment against Migraine with Aura and Menstrual Migraine
por: Shaik, Munvar Miya, et al.
Publicado: (2015)

The NRP1 migraine risk variant shows evidence of association with menstrual migraine
por: Pollock, Charmaine E., et al.
Publicado: (2018)

Urinary Proteomics Reveals Promising Biomarkers in Menstrually Related and Post-Menopause Migraine
por: Bellei, Elisa, et al.
Publicado: (2021)

Altered trigeminal system excitability in menstrual migraine patients
por: Varlibas, Ayhan, et al.
Publicado: (2009)

Treatment of menstrual migraine; multidisciplinary or mono-disciplinary approach
por: Witteveen, Hester, et al.
Publicado: (2017)

Validation of diagnostic ICHD-3 criteria for menstrual migraine
por: Verhagen, Iris E, et al.
Publicado: (2022)

Genetics of Menstrual Migraine and Their Association with Female Hormonal Factors
por: Kalarani, Iyshwarya B., et al.
Publicado: (2022)

Menstrual migraine is caused by estrogen withdrawal: revisiting the evidence
por: Raffaelli, Bianca, et al.
Publicado: (2023)

Menstrual Headache in Women with Chronic Migraine Treated with Erenumab: An Observational Case Series
por: Ornello, Raffaele, et al.
Publicado: (2021)

Plasma calcitonin gene‐related peptide (CGRP) in migraine and endometriosis during the menstrual cycle
por: Raffaelli, Bianca, et al.
Publicado: (2021)

Contraceptive-induced amenorrhoea leads to reduced migraine frequency in women with menstrual migraine without aura
por: Vetvik, Kjersti Grøtta, et al.
Publicado: (2014)

EHMTI-0188. Contraceptive-induced amenorrhoea leads to reduced migraine frequency in women with menstrual migraine
por: MacGregor, EA, et al.
Publicado: (2014)

Pure menstrual migraine with sensory aura: a case report
por: Chen, Jiann-Jy, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dqp7r045f1v5f6hi61ie1o1o8u